International Journal of Immunological Nursing

COVID 19 ASSOCIATED MUCORMYCOSIS (BLACK FUNGUS)

  1. REJANI R ✉

Abstract

Mucormycosis is an infection caused by a group of filamentous moulds within the order Mucorales.Infections may result from ingestion of contaminated food, inhalation of spores into the nares orlungs, or inoculation into disrupted skin or wounds. In developed countries, mucormycosis occursprimarily in severely immunocompromised hosts. Only 6 to 10% of cases occur in subjects with nounderlying disease. In contrast, in developing countries, most cases of mucormycosis occur in personswith poorly controlled diabetes mellitus or in immunocompetent subjects following trauma.Mucormycosis exhibits a marked propensity to invade blood vessels, leading to thrombosis, necrosis,and infarction of tissue.

References (21)

  1. Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a
  2. clinical and diagnostic perspective from China. Mycopathologia. 2020; 185(4): 599–606.
  3. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, Puri GD, Chakrabarti A,
  4. Agarwal R. Coronavirus disease (COVID-19) associated mucormycosis (CAM): case report and
  5. systematic review of literature. Mycopathologia. 2021; 186(2): 289–298.
  6. Prakash H, Ghosh AK, Rudramurthy SM, Singh P, Xess I, Savio J, Pamidimukkala U, Jillwin J,
  7. Varma S, Das A, Panda NK. A prospective multicenter study on mucormycosis in India:
  8. Epidemiology, diagnosis, and treatment. Med Mycol. 2019; 57(4): 395–402.
  9. Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology,
  10. presentation, and management. Clinical Microbiol Rev. 2005; 18(3): 556–569.
  11. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and
  12. clinical manifestations of mucormycosis. Clin Infect Dis. 2012 Feb 1; 54(suppl_1): S23–34.
  13. Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an
  14. update. J Fungi. 2020; 6(4): 265.
  15. Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more
  16. common mycoses? Clin Microbiol Infect. 2014; 20(Suppl 6): 74–81.
  17. Lin E, Moua T, Limper AH. Pulmonary mucormycosis: clinical features and outcomes. Infection.
  18. ; 45(4): 443–448.
  19. Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin North Am. 2016; 30(1):
  20. Sahota R, Gambhir R, Anand S, Dixit A. Rhinocerebral mucormycosis: report of a rare case.
  21. Ethiop J Health Sci. 2017; 27(1): 85–90.

Read more of it

Subscribe to one journal or build your own list of several. One invoice, one payment, access for a full year.

Subscribe to journals →

Publish your article

Peer-reviewed journals across every subject, with open access options. Send your manuscript to the right editor today.

Publish with us → Calculate your APC
Support